Perspective Therapeutics, Inc. [ISR]

Source: 

Company Overview

Perspective Therapeutics, Inc is developing the next generation of precision-targeted alpha therapies (“TAT”) for oncology that have the potential to treat a large population of cancer patients across multiple tumor types, including those with metastatic disease.